Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: epirubicin|DRUG: cyclophosphamide|DRUG: docetaxel|DRUG: trastuzumab
Sponsor: Accelerated Community Oncology Research Network
Collaborators: Aventis Pharmaceuticals